CI - Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth Analyst Says | Benzinga
Piper Sandler has initiated coverage on Cigna Corporation (NYSE:CI), a diversified managed care and healthcare delivery organization specializing in commercial insurance markets and pharmacy services.
The analyst writes, “We believe Cigna has a unique and defensible leadership position in the fast-growing specialty pharmacy market which, together with the company’s insurance segment and core PBM business, should support LT-adjusted EPS growth at a 10-14% CAGR.”
Related: Cigna Crushes Q1 Estimates: Revenue Soars With Evernorth’s Explosive Growth.
The company’s Cigna Healthcare and Evernorth Health Services businesses complement one another and empower Cigna to continue delivering premium adjusted EPS growth against the LT target of 10-14% per year, the Piper analyst writes.
Cigna grew adjusted EPS at a 13%+ ...